StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$646.87−6.22 (-0.95%)

Close on Nov 18, 2026Market cap $18.09BP/E 35.9Yield –

Medpace price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Medpace's price to book ratio was 42.8× on Nov 11, 2026, against 56.8× a year earlier. Over the last 5 years it ranged from 5.0× to 95.3×, with a median of 18.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202642.8×−11.1
2025Dec 31, 202553.9×+42.2
2024Dec 31, 202411.7×−8.3
2023Dec 29, 202320.0×+1.1
2022Dec 30, 202218.9×+10.2
2021Dec 31, 20218.7×+2.4
2020Dec 31, 20206.3×+1.9
2019Dec 31, 20194.4×+1.0
2018Dec 31, 20183.3×+0.9
2017Dec 29, 20172.5×+0.1
2016Dec 30, 20162.4×–

More Medpace figures

See a number that looks wrong?